Gino A. Bonanotte
Analyst · Goldman Sachs
Thank you, Greg. Q3 2014 revenue was $1.4 billion, a decrease of 5% from last year. GAAP operating earnings were $207 million or 14% of sales. Non-GAAP operating earnings were $259 million or 18% of sales. Operating cash flow was a use of $115 million, driven by $397 million of U.S. pension contributions during the quarter related to our pension de-risking actions announced in September. On a GAAP basis, earnings per share from continuing operations were $0.27 compared to $0.98 per share in the third quarter of 2013. Non-GAAP net earnings from continuing operations were $0.62 per share compared to $1.08 in the year-ago quarter, which included a $0.35 benefit from the formation of our international holding company in 2013. Accelerated cost reductions and higher sales both drove favorable EPS relative to our outlook. For the remainder of this call, we will reference non-GAAP financial results, unless otherwise noted. Q3 Products sales were $921 million, down 8% versus the prior year, driven primarily by lower device sales. Despite this decline, our North America business again improved sequentially. In addition, our PCR business grew in North America and Europe & Africa, as Europe & Africa posted another strong quarter. Systems revenue was down slightly versus the year-ago quarter, although revenue was up both in North America and Europe & Africa. Finally, product backlog was up sequentially, led by North America. And coupled with a healthy pipeline, we believe the North American market is beginning to recover. Products segment operating income was $175 million or 19% of sales, down from $204 million or 20% of sales in Q3 2013. The decline in operating income was a function of lower sales, offset by cost reductions. Turning to Services. When normalizing for iDEN, Services grew at 2% for the quarter. Services sales in Q3 were $515 million, a decrease of less than 1% from the prior year. Systems integration and lifecycle services were flat, while Managed Services was up double digits, and Smart Public Safety grew single digits versus the prior year quarter. Integration services was up slightly on large projects, such as TETRA deals in Europe and the North America LA-RICS LTE deployment. Lifecycle support services held steady, with significant contributions from system maintenance contracts and software upgrade agreements. Managed Services was up double digits, with strong growth across all region, while our Smart Public Safety business is being driven by more command and control revenue from early market traction. We are pleased with the performance and competitive position of these new services and look for continued growth. Operating income in the Services segment was $84 million, down approximately $8 million to 16.3% of revenue, driven primarily by lower iDEN sales. Services gross margin was in the mid-30s, generally consistent with past performance and up from Q2. Total company operating expenses from continuing operations were $434 million, down $43 million or 9% from the year-ago quarter, driven by continued cost-reduction activities. We now expect 2014 OpEx to be down more than $200 million versus the prior year. Our year-to-date operating expenses are down $120 million, the key drivers of which include staff reductions, lower 2014 incentives and organizational efficiencies across all aspects of our business. Approximately 1/3 of the savings has been in R&D, with the balance of savings in SG&A. Examples of actions we have driven include consolidation of testing processes and lab sites, leveraging development teams and support cost and eliminating staff or moving work to lower-cost location. In selling and marketing, we have simplified the organizational structure and reduced sales support cost by lowering our overall nonquota-carrying employee base. In G&A, we've simplified our management structure across spans and layers while increasing the use of centralized services. And while we're relatively pleased with our progress on cost, there is more work to do. Shifting to other income and expense. This line item was a net expense of $29 million compared to a net gain of $5 million in the year-ago quarter. We expect this line item to be approximately $45 million per quarter, primarily driven by interest expense. With respect to taxes, our Q3 effective rate was 33%, and we expect our Q4 effective tax rate to be the same. We still expect our cash tax rate to be in the range of 10% to 15% for full year 2014 and a cash tax rate of approximately 15% through 2019. Turning to cash flow. Cash flow from operating activities in the third quarter was a net usage of $115 million, which includes a $397 million contribution related to the U.S. pension transaction announced in September. For the year, we expect operating cash flow from continuing operations to be a net use of approximately $250 million. This includes the incremental funding of our U.S. plan, of which $650 million remains to be funded in Q4. Excluding these discretionary pension contributions related to the pension de-risking transaction, the annual operating cash flow would be approximately $550 million, as previously guided. Let me also remind you that our actions taken on pension de-risking will require no U.S. cash contributions for the next 5 to 6 years. Let me also reiterate our conviction to retain our investment-grade rating as we move forward with returning the proceeds in a timely manner. We ended Q3 with $2.8 billion in total cash and $3.4 billion in debt. In Q3, we repurchased $650 million of stock or approximately 10.4 million shares at an average price of $62.63 per share. Since the program's inception in the third quarter of 2011, we've reduced our net share count by 30% at an average price of $52.08 a share. In addition, we paid $78 million in dividends during the quarter. In discontinued operations, Q3 revenues for Enterprise grew 2% year-over-year to $605 million in the quarter. We saw solid growth in both North America and Europe throughout most of the portfolio. Now turning to our outlook. We expect Q4 sales to decline by 1% to 3%. This outlook is consistent with our prior full year view of a low to mid-single-digit sales decline, excluding iDEN. We expect non-GAAP operating earnings per share from continuing operations to be between $1.13 and $1.19 per share in Q4. As a reminder, Q4 2013 included a $0.42 benefit from the formation of our international holding company. I'll now turn it back to Greg.